Monday, October 7, 2024 HIVR4P 2024 Research Highlights: Reproductive Health While on PrEP and Signals to Guide HIV Vaccines and Cure Transmission electron micrograph of HIV-1 virus particles (pink) replicating from the plasma membrane of an H9 T cell (purple). Image captured at the NIAID Integrated Research Facility in Fort Detrick, Maryland. Credit: NIAID New NIAID-supported science presented at the 2024 HIV Research for Prevention conference in Lima, Peru features a breadth of HIV discovery and translational findings and enriches the evidence base on HIV prevention within the context of reproductive health. Learn More National Institute of Allergy and Infectious Diseases  |  National Institutes of Health

---

Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact Subscriber Help. Your subscription may be removed if you do not open our emails for a six-month period. 

This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID).

                           

---

This email was sent to myhcistech.healthnews360@blogger.com using GovDelivery Communications Cloud on behalf of: National Institute of Allergy and Infectious Diseases · 5601 Fishers Lane · Bethesda, MD 20892 · 1-866-284-4107